Reg3A Antibody (019) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-89856PCP
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Immunohistochemistry-Paraffin
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 019
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Reg3A Antibody (019) [PerCP]
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human Reg3A (Uniprot#: Q06141-1; Met 1-Asp 175).
Specificity
No cross-reactivity in ELISA with: Human REG3GMouse REG3AHuman REG1B
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Reg3A Antibody (019) [PerCP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Reg3A
Long Name
Regenerating Islet-derived IIIa
Alternate Names
Lithostathine 3, PAP2, REG3A
Gene Symbol
REG3A
Additional Reg3A Products
Product Documents for Reg3A Antibody (019) [PerCP]
Product Specific Notices for Reg3A Antibody (019) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...